Update To Anti-Lesbian Drug?

Margie Nichols, Ph.D.by Margie Nichols, Ph.D.

By coincidence, as the news about a drug that can ‘de-masculinize’ female fetuses hit the blogs, one of my sex therapy listserves began a fascinating discourse about the prevalence of PCOS in female to male transgender people.  Polycystic Ovary Syndrome (PCOS) is a genetically transmitted syndrome with some potentially distressing symptoms and consequences.  However, in the population of young women presenting themselves for hormone treatment to transition from a female to a male body, PCOS is relatively prevalent.

     Since PCOS is a syndrome caused by an excess of androgens – male hormones – in biological female, this again raises the issue of hormones in both gender identity and sexual orientation.  Certainly hormones could not be the sole factor determining these complex psycho-social phenomenon, but it looks like they may play a role and that the two- gender and orientation – are at least partially intertwined.

OUR OFFICE LOCATIONS

235 9th Street
Jersey City, NJ 07302
1119 Raritan Ave.
Highland Park, NJ 08904
90 West Main Street
Freehold, NJ 07728